我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

双黄连注射液导致类过敏的物质基础及作用机理(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2020年05期
页码:
90-97
栏目:
综述
出版日期:
2020-12-30

文章信息/Info

Title:
Material Basis and Mechanism of Anaphylactoid Induced by Shuanghuanglian Injection
文章编号:
1000-2723(2020)05-0090-08
作者:
韩依伦夏恒段金连段为钢△
云南中医药大学中医药学分子生物学重点实验室,云南 昆明 650500
Author(s):
HAN Yilun XIA Heng DUAN Jinlian DUAN Weigang
Key Laboratory of Molecular Biology for Sinomedicine, Yunnan University of Chinese Medicine, Kunming 650500, China
关键词:
双黄连注射液类过敏反应大分子物质基础作用机理
Keywords:
Shuanghuanglian injectionanaphylactoid reactionmacromoleculematerial basisaction mechanism
分类号:
R286;R259
DOI:
10.19288/j.cnki.issn.1000-2723.2020.05.016
文献标识码:
A
摘要:
双黄连注射液由金银花、黄芩、连翘制备而成,可清热解毒、宣散风热,作用迅速,有良好的生物利用度,临床上治疗上呼吸道感染、肺炎、扁桃体炎等病症,均取得了良好的效果。近年中药注射剂所致不良反应显著增多,双黄连注射液所导致的不良反应总是排列在首位,其不良反应涉及人体多个系统和器官,如皮肤、消化系统、心血管等系统的损伤,严重者甚至会发生过敏性休克。目前双黄连注射液致敏原因尚存争议,本文从中医理论、物质基础、类过敏反应的机制等方面综述,对其导致类过敏的原因进行讨论,以求为增加双黄连注射液的安全性提供建议。
Abstract:
Shuanghuanglian injection is a Chinese formula prepared from three Traditional Chinese Medicines (TCMs) including Lonicera Japonica (Jinyinhua), Radix Scutellariae (Huangqin) and Fructus Forsythiae (Lianqiao), which can clear heat and detoxify, disperse wind and heat, act quickly, have good bioavailability, and have good results in the treatment of upper respiratory tract infection, pneumonia, tonsillitis and other diseases. In recent years, the adverse reactions caused by traditional Chinese medicine injection have increased significantly, and the adverse reactions caused by Shuanghuanglian injection are always in the first place. the adverse reactions involve the injury of many systems and organs of the human body, such as skin, digestive system, cardiovascular system and so on. In severe cases, anaphylactic shock may even occur. At present, the cause of sensitization of Shuanghuanglian injection is still controversial. This article will review the theory of traditional Chinese medicine, the material basis, the mechanism of anaphylactoid and other aspects, and discuss the causes of anaphylactoid, in order to provide suggestions for increasing the safety of Shuanghuanglian injection.

参考文献/References

[1] 周东浩,夏菲菲,刘震超,等. 《黄帝内经》卫气防御作用特性概览[J]. 中国中医基础医学杂志,2019,25(5):573-574.
[2] 陶飞祥,刘冰梅. 治荨麻疹当分内风外风[J]. 中国民间疗法,2020,28(4):11-12.
[3] 王倩,蔡念宁,周冬梅,等. 运用赵炳南经验从寒热辨治荨麻疹探析[J]. 北京中医药,2020,39(4):348-350.
[4] 王茜. 中药注射液不良反应213例分析[J]. 临床合理用药杂志,2019,12(19):13-14.
[5] 杨荣英. 五种常用中药注射液的不良反应分析[J]. 海峡药学,2017,29(1):209-211.
[6] 王丽娜. 双黄连注射剂致过敏性休克66例文献分析[J]. 中国医院用药评价与分析,2010,10(4):368-370.
[7] 杨燕妮,冯雪梅,何海明,等. 144例双黄连注射剂不良反应/事件报告分析[J]. 广东药学院学报,2014,30(2):210-213.
[8] 唐春燕,曾立威,林昊,等. 广西2009年双黄连注射剂不良反应/不良事件报告分析[J]. 中国药房,2010,21(16):1501-1504.
[9] HAN J,ZHAO Y,ZHANG Y,et al. RhoA/ROCK Signaling pathway mediates Shuanghuanglian Injection-induced pseudo-allergic reactions[J]. Front Pharmacol,2018,9:87.
[10] 李彦林. 双黄连注射液致敏反应特征及致敏标志物研究[D]. 北京:北京协和医学院,2016.
[11] 卞婷婷,安益强,汤道权,等. HPLC法同时测定双黄连冻干粉中11个成分的含量[J]. 药物分析杂志,2012,32(1):52-56.
[12] 殷华,柯瑾,段为钢. 中药注射剂大分子物质是活性成分还是杂质?[J]. 医学争鸣,2018,9(2):26-30.
[13] 殷华,李月,司季青,等. 4种中药注射剂大分子富集液的重复给药毒性实验研究[J]. 云南中医学院学报,2017,40(4):14-20.
[14] 袁丽燕,刘屏,胡园,等. 不同偶联率绿原酸全抗原的免疫原性研究[J]. 中国中药杂志,2010,35(20):2756-2759.
[15] 何洲,屈会化,王雪茜,等. 绿原酸作为半抗原的致敏性研究[J]. 北京中医药大学学报,2010,33(10):667-669.
[16] 彭博,贺蓉,徐启华,等. RBL-2H3和P815细胞用于建立体外肥大细胞脱颗粒模型的比较研究(英文)[J]. 中国天然药物,2011,9(3):227-231.
[17] 帅维维,朱丹凤,蒋宝平,等. 绿原酸对BN大鼠的致敏性研究[J]. 时珍国医国药,2019,30(7):1566-1568.
[18] 汪芳,李存玉,郑云枫,等. 双黄连注射液中8种主要成分对RBL-2H3细胞的影响[J]. 中成药,2016,38(7):1615-1617.
[19] 李恒华,罗超利,黄崇刚,等. 绿原酸的致敏作用研究[J]. 中国药房,2015,26(13):1766-1769.
[20] 冯宇飞,井中旭,王艳宏,等. 双黄连粉针3种主要有效成分致动物类过敏性实验研究[J]. 中医药学报,2014,42(2):33-36.
[21] 冯文宇,刘明华,肖顺汉,等. 金银花精提取物与粗提取物注射液的主动全身过敏试验研究[J]. 时珍国医国药,2008,19(12):2847-2848.
[22] 段金连,李月,张路梅,等. 中药注射剂中药材的微生物污染(英文)[J]. 云南中医学院学报,2019,42(4):1-8.
[23] 云宇,王蕾,段为钢. 从机体处理物质的方式认识代谢和免疫的一致性[J]. 医学争鸣,2017,8(1):24-27.
[24] 柯瑾,张陆勇,殷华,等. 大分子物质对中药注射剂的安全性影响[J]. 中成药,2014,36(4):855-859.
[25] 李月,段金连,白雯,等. 大分子物质对中药注射剂外观颜色的影响[J]. 中医药导报,2018,24(23):43-48.
[26] LAYTON L L,PANZANI R,CORTESE T A. Coffee-reaginic human sera tested in human volunteers and macaque monkeys. Absence of reactions to chlorogenic acid[J]. Int Arch Allergy Appl Immunol,1968,33(5):417-427.
[27] XU Y,LIU C,DOU D,et al. Evaluation of anaphylactoid constituents in vitro and in vivo[J]. Int Immunopharmacol,2017,43:79-84.
[28] XU Y,DOU D,RAN X,et al. Integrative analysis of proteomics and metabolomics of anaphylactoid reaction induced by Xuesaitong injection[J]. J Chromatogr A,2015,1416:103-111.
[29] 易艳,梁爱华,李春英,等. 溶媒及配制后存放时间对注射用双黄连类过敏反应的影响[J]. 中国中药杂志,2015,40(14):2723-2726.
[30] 胡宗苗,张恩户,刘继平,等. 双黄连注射剂中连翘酯苷A致敏家兔后血清中特异性抗体的测定[J]. 中成药,2016,38(9):2045-2048.
[31] WANG F,LI C Y,ZHENG Y F,et al. Identification of the allergenic ingredients in Reduning Injection by ultrafiltration and high-performance liquid chromatography[J]. J Immunol Res,2016,2016:4895672.
[32] TAGHAVI M,KHOSRAVI A,MORTAZ E,et al. Role of pathogen-associated molecular patterns(PAMPS)in immune responses to fungal infections[J]. Eur J Pharmacol,2017,808:8-13.
[33] ZHONG Y,KINIO A,SALEH M. Functions of NOD-like receptors in human diseases[J]. Front Immunol,2013,4:333.
[34] MEUNIER E,BROZ P. Evolutionary convergence and divergence in NLR function and structure[J]. Trends Immunol,2017,38(10):744-757.
[35] MANGAN M S J,OLHAVA E J,ROUSH W R,et al. Targeting the NLRP3 inflammasome in inflammatory diseases[J]. Nat Rev Drug Discov,2018,17(9):688.
[36] EISENACHER K,KRUG A. Regulation of RLR-mediated innate immune signaling--it is all about keeping the balance[J]. Eur J Cell Biol,2012,91(1):36-47.
[37] MATSUMIYA T,IMAIZUMI T,YOSHIDA H,et al. Antiviral signaling through retinoic acid-inducible gene-I-like receptors[J]. Arch Immunol Ther Exp(Warsz),2011,59(1):41-48.
[38] VILAYSANE A,MURUVE D A. The innate immune response to DNA[J]. Semin Immunol,2009,21(4):208-214.
[39] SZEBENI J,MUGGIA F,GABIZON A,et al. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products:prediction and prevention[J]. Adv Drug Deliv Rev,2011,63(12):1020-1030.
[40] MCNEIL B D,PUNDIR P,MEEKER S,et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions[J]. Nature,2015,519(7542):237-241.
[41] LIHUA L,YOSHIKAWA S,OHTA T,et al. Large particulate allergens can elicit mast cell-mediated anaphylaxis without exit from blood vessels as efficiently as do small soluble allergens[J]. Biochem Biophys Res Commun,2015,467(1):70-75.
[42] 潘卫松,刘肃,符路娣,等. 中药注射剂降压物质检查结果与类过敏反应的相关性研究[J]. 药物分析杂志,2015,35(8):1346-1353.
[43] 韩森,李城,魏佩煌,等. 注射用双黄连诱发肥大细胞脱颗粒的早期生物学效应[J]. 环球中医药,2018,11(6):842-845.
[44] DING Y,CHE D,LI C,et al. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca2+ fluctuations[J]. Int Immunopharmacol,2019,66:185-197.
[45] ZHANG T,CHE D,LIU R,et al. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2[J]. Eur J Immunol,2017,47(11):1949-1958.
[46] SUBRAMANIAN H,GUPTA K,ALI H. Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense,pseudoallergic drug reactions,and chronic inflammatory diseases[J]. J Allergy Clin Immunol,2016,138(3):700-710.
[47] QIU S,LIU Z,HOU L,et al. Complement activation associated with polysorbate 80 in beagle dogs[J]. Int Immunopharmacol,2013,15(1):144-149.
[48] GAO Y,HOU R,HAN Y,et al. Shuang-Huang-Lian injection induces an immediate hypersensitivity reaction via C5a but not IgE[J]. Sci Rep,2018,8(1):3572.
[49] WEISZHAR Z,CZUCZ J,REVESZ C,et al. Complement activation by polyethoxylated pharmaceutical surfactants:Cremophor-EL,Tween-80 and Tween-20[J]. Eur J Pharm Sci,2012,45(4):492-498.
[50] 刘雪莹,刘春琰,徐煜彬,等. 生脉及参麦注射液对人血清补体系统类过敏评价[J]. 辽宁中医杂志,2017,44(3):571-573.
[51] 张嘉,李贻奎,李连达,等. 补体系统激活在吐温80导致类过敏反应中的作用[J]. 毒理学杂志,2009,23(6):457-459.
[52] BENDER L,WEIDMANN H,ROSE-JOHN S,et al. Factor XII-driven inflammatory reactions with implications for anaphylaxis[J]. Front Immunol,2017,8:1115.
[53] CORBIER A,LE BERRE N,RAMPE D,et al. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat[J]. Toxicol Sci,2011,121(2):417–427.
[54] 徐煜彬,窦德强. 中药注射剂类过敏研究进展[J]. 中国中药杂志,2015,40(14):2765-2773.
[55] 云宇,侯肖霖,殷华,等. 4种去大分子中药注射剂的稳定性研究[J]. 云南中医学院学报,2016,39(4):20-25.

备注/Memo

备注/Memo:
收稿日期: 2020 - 08- 03
基金项目: 国家自然科学基金项目(81560645);云南省中医药联合专项重点项目(编号:2017FF117-032) ?/div>
第一作者简介: 韩依伦(1995-),男,在读硕士研究生,研究方向:中药注射剂安全性提高。?/div>
?通信作者: 段为钢, E-mail:deardwg@126.com
更新日期/Last Update: 1900-01-01